肝硬化并发静脉血栓栓塞的研究进展

张鑫彤; 祁兴顺; 高帆; 郭晓钟

doi:10.3969/j.issn.1001-5256.2016.10.043

肝硬化并发静脉血栓栓塞的研究进展

DOI: 10.3969/j.issn.1001-5256.2016.10.043

1. 第四军医大学研究生院
2. 沈阳军区总医院消化内科
3. 解放军第二〇二医院医务处

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1945
- HTML全文浏览量: 27
- PDF下载量: 460
- 被引次数: 0
出版历程
- 收稿日期: 2016-06-07
- 出版日期: 2016-10-20

Research advances in venous thromboembolism in patients with liver cirrhosis

Postgraduate College,Fourth Military Medical University

摘要

摘要:
传统观点认为肝硬化常伴有出血倾向,主要与凝血因子减少、纤溶亢进、血小板减少及门静脉压力增高有关。也有研究认为肝硬化处于高凝状态,易发生静脉血栓栓塞,严重影响预后。概述了肝硬化并发静脉血栓栓塞的流行病学特征、危险因素及静脉血栓栓塞预防的意义,以供指导临床实践。
- 肝硬化 /
- 静脉血栓栓塞 /
- 综述
Abstract:
Traditionally,liver cirrhosis has a bleeding tendency due to the reduction in blood coagulation factors,hyperfibrinolysis,thrombocytopenia,and increased portal hypertension. Some studies show that the patients with live cirrhosis are in a state of hypercoagulability and tend to develop venous thromboembolism,which greatly affects the patients' prognosis. This article reviews the epidemiological features and risk factors of venous thromboembolism,as well as the significance of prevention of venous thromboembolism in patients with liver cirrhosis,so as to guide clinical practice.
- liver cirrhosis /
- venous thromboembolism /
- review

HTML全文

参考文献(27)

[1]TRIPODI A,SALERNO F,CHANTARANGKUL V,et al.Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests[J].Hepatology,2005,41(3):553-558.

[2]TRIPODI A,PRIMIGNANI M,CHANTARANGKUL V,et al.An imbalance of pro-vs anti-coagulation factors in plasma from patients with cirrhosis[J].Gastroenterology,2009,137(6):2105-2111.

[3]SOGAARD KK,HORVATHPUHO E,GRONBAEK H,et al.Risk of venous thromboembolism in patients with liver disease:a nationwide population-based case-control study[J].Am J Gastroenterol,2009,104(1):96-101.

[4]ZHANG X,QI X,de STEFANO V,et al.Epidemiology,risk factors,and in-hospital mortality of venous thromboembolism in liver cirrhosis:a single-center retrospective observational study[J].Med Sci Monit,2016,24(22):969-976.

[5]TSOCHATZIS EA,BOSCH J,BURROUGHS AKJ.Liver cirrhosis[J].Lancet,2014,383(9930):1749-1761.

[6]GOLDHABER SZ,BOUNAMEAUX H.Pulmonary embolism and deep vein thrombosis[J].Lancet,2012,379(9828):1835-1846.

[7]KYRLE A,EICHINGER S.Deep vein thrombosis[J].Lancet,2005,365(9465):1163-1174.

[8]GOLDHABER SZ.Pulmonary embolism[J].Lancet,2004,363(9417):1295-1305.

[9]ZHAO YQ.Research status of renous thromboembolism in China[J].Chin J Intern Med,2005,44(2):7-8.(in Chinese)赵永强.我国静脉血栓栓塞症的研究现状[J].中华内科杂志,2005,44(2):7-8.

[10]QI X,HAN G,FAN D.Management of portal vein thrombosis in liver cirrhosis[J].Nat Rev Gastroenterol Hepatol,2014,11(7):435-446.

[11]QI X,REN W,de STEFANO V,et al.Epidemiology of venous thromboembolism in patients with liver diseases:a systematic review and meta-analysis[J].Intern Emerg Med,2015,10(2):205-217.

[12]ALDAWOOD A,ARABI Y,ALJUMAH A,et al.The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients[J].Thromb J,2011,9(1):1.

[13]ALI M,ANANTHAKRISHNAN AN,MCGINLEY EL,et al.Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis:a nationwide analysis[J].Dig Dis Sci,2011,56(7):2152-2159.

[14]BARCLAY SM,JEFFRES MN,NGUYEN K,et al.Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease[J].Pharmacotherapy,2013,33(4):375-82.

[15]DABBAGH O,OZA A,PRAKASH S,et al.Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease[J].Chest,2010,137(5):1145-1149.

[16]LESMANA CRA,INGGRIANI S,CAHYADINATA L,et al.Deep vein thrombosis in patients with advanced liver cirrhosis:a rare condition?[J].Hepatol Int,2010,4(1):433-438.

[17]NORTHUP G,MCMAHON MM,RUHL AP,et al.Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism[J].Am J Gastroenterol,2006,101(7):1524-1528.

[18]WALSH KA,LEWIS DA,CLIFFORD TM,et al.Risk factors for venous thromboembolism in patients with chronic liver disease[J].Ann Pharmacother,2013,47(3):333-339.

[19]HUERTA C,JOHANSSON S,WALLANDER MA,et al.Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom[J].Arch Intern Med,2007,167(9):935-943.

[20]GARCIA-FUSTER MJ,ABDILLA N,FABIA MJ,et al.Venous thromboembolism and liver cirrhosis[J].Rev Esp Enferm Dig,2008,100(5):259-262.

[21]GULLEY D,TEAL E,SUVANNASANKHA A,et al.Deep vein thrombosis and pulmonary embolism in cirrhosis patients[J].Dig Dis Sci,2008,53(11):3012-3017.

[22]Di MINNO MN,TUFANO A,RUSOLILLO A,et al.High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism[J].World J Gastroenterol,2010,16(48):6119-6122.

[23]WU H,NGUYEN GC.Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study[J].Clin Gastroenterol Hepatol,2010,8(9):800-805.

[24]MOOREHEAD KJ,JEFFRES MN,MUELLER SW.A retrospective cohort analysis of pharmacologic VTE prophylaxis and padua prediction score in hospitalized patients with chronic liver disease[J].J Pharm Pract,2015.[Epub ahead of print]

[25]SHATZEL J,DULAI S,HARBIN D,et al.Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis:a single-center retrospective cohort study[J].J Thromb Haemost,2015,13(7):1245-1253.

[26]VILLA E,CAMMA C,MARIETTA M,et al.Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis[J].Gastroenterology,2012,143(5):1253-1260.

[27]INTAGLIATA NM,HENRY Z,SHAH N,et al.Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding[J].Liver Int,2014,34(1):26-32.

施引文献

资源附件(0)

访问统计